OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
7702$425.0057

JMS Co Ltd

Medical Equipment, Supplies & DistributionVerified

JMS Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.6, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.79, suggesting it can cover its short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics for JMS Co Ltd are weak, with a return on equity (ROE) of 0.0022 and a return on assets (ROA) of 0.0.0011, both significantly below typical industry benchmarks. The company's operating margin is 1.20%, and its net margin is 0.13%, indicating limited efficiency in converting revenue into profit. Geographically, JMS Co Ltd operates in five segments: Japan, Singapore, China, Philippines, and Germany. The company's revenue is distributed across these regions, but the input data does not provide specific revenue concentrations for each segment. The lack of detailed segmental revenue data limits the ability to assess geographic risk exposure. The company's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. Historical revenue data shows a total revenue of 69.75 billion JPY, but without comparative data from prior periods, it is difficult to assess year-over-year growth. Risk factors for JMS Co Ltd include a medium liquidity risk, as indicated by the negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential reported. The risk assessment also notes that the company's liquidity position could be a concern if cash flow from operations does not improve. Recent events and filings for JMS Co Ltd include the latest actual EPS of 3.65 JPY and actual revenue of 69.75 billion JPY, as reported by analysts. No specific recent filings or transcripts are provided in the input data to indicate significant corporate developments.

30-day price · 7702+5.00 (+1.2%)
Low$418.00High$447.00Close$430.00As of17 May, 00:00 UTC
Profile
CompanyJMS Co Ltd
Ticker7702.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. JMS Co Ltd is a Japan-based company engaged in the manufacture and sale of medical equipment and drugs, operating through five geographical segments and generating revenue from infusion and nutrition products, dialysis products, surgery products, blood and cell products, and related services.

Classification. JMS Co Ltd is classified under the Healthcare Services & Equipment business sector within the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

JMS Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.6, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.79, suggesting it can cover its short-term obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics for JMS Co Ltd are weak, with a return on equity (ROE) of 0.0022 and a return on assets (ROA) of 0.0.0011, both significantly below typical industry benchmarks. The company's operating margin is 1.20%, and its net margin is 0.13%, indicating limited efficiency in converting revenue into profit. Geographically, JMS Co Ltd operates in five segments: Japan, Singapore, China, Philippines, and Germany. The company's revenue is distributed across these regions, but the input data does not provide specific revenue concentrations for each segment. The lack of detailed segmental revenue data limits the ability to assess geographic risk exposure. The company's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. Historical revenue data shows a total revenue of 69.75 billion JPY, but without comparative data from prior periods, it is difficult to assess year-over-year growth. Risk factors for JMS Co Ltd include a medium liquidity risk, as indicated by the negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential reported. The risk assessment also notes that the company's liquidity position could be a concern if cash flow from operations does not improve. Recent events and filings for JMS Co Ltd include the latest actual EPS of 3.65 JPY and actual revenue of 69.75 billion JPY, as reported by analysts. No specific recent filings or transcripts are provided in the input data to indicate significant corporate developments.
Key takeaways
  • JMS Co Ltd has a moderate debt-to-equity ratio of 0.6, indicating a balanced capital structure.
  • The company's profitability is weak, with ROE and ROA at 0.0022 and 0.0011, respectively.
  • JMS Co Ltd operates in five geographical segments, but revenue concentration data is not provided.
  • The company's liquidity position is medium risk, with a negative net cash position after subtracting total debt.
  • Analyst estimates indicate a recent actual EPS of 3.65 JPY and revenue of 69.75 billion JPY.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$69.75B
Gross profit$15.93B
Operating income$838.0M
Net income$89.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.47B
CapEx-$3.04B
Free cash flow$439.0M
Total assets$81.43B
Total liabilities$40.60B
Total equity$40.84B
Cash & equivalents$5.51B
Long-term debt$24.55B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$425.00
Market cap$10.43B
Enterprise value$29.46B
P/E117.1
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income35.2
EV/OCF20.1
P/B0.3
P/Tangible book0.3
Tangible book$40.84B
Net cash-$19.04B
Current ratio1.8
Debt/Equity0.6
ROA0.1%
ROE0.2%
Cash conversion16.5%
CapEx/Revenue-4.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric7702Activity
Op margin1.2%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin0.1%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin22.8%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.4%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity60.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Observations
IR observations
Last actual EPS3.65 JPY
Last actual revenue69,749,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:07 UTC#8ff9c877
Market quoteclose JPY 425.00 · shares 0.02B diluted
no public URL
2026-05-10 05:07 UTC#a0fdf6c4
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:09 UTCJob: 77dbb718